Delivery Order SPE2DB20D1100-SPE2DB24FD8U9

Award Date 9/17/24
Potential Completion Date 9/18/24
Potential Value $5.2K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corporation's Corporate Office division. The contract, valued at $1,014.78, is for the supply of FYCOMPA 10 MG TABLET 30S, a pharmaceutical product. The contract has an ultimate completion date of October 4, 2024 and uses a firm fixed-price pricing type. This order is part of AmerisourceBergen's broader Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This is a delivery order contract awarded to Amerisourcebergen Drug Corp's Corporate Office division by the Defense Logistics Agency (DLA) Troop Support Medical. The contract is for the supply of FYCOMPA 6 MG TABLET 30S, a pharmaceutical product, with a ceiling value of $7,171.10 and a period of performance through September 10, 2024. The contract is a firm-fixed price delivery order with no set-aside designation. Amerisourcebergen is a major supplier of pharmaceutical products and medical...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,096.77, is for the supply of FYCOMPA 0.5 MG/ML ORAL SUSP 340ML, a pharmaceutical product. The contract has a firm fixed price pricing type and an ultimate completion date of March 31, 2025. This contract is not designated as a set-aside. AmerisourceBergen holds a significant $999,999,999...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,240.52 delivery order contract is for the supply of FYCOMPA 8 MG TABLET 30S, a pharmaceutical product. The contract has an ultimate completion date of December 3, 2024 and is a firm fixed-price contract. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,051.80 Firm Fixed Price Delivery Order contract has an ultimate completion date of April 10, 2025 and is not designated with a set-aside. The contract provides for the delivery of FYCOMPA 12 MG TABLET 30S, a pharmaceutical product. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $4,177.08, is for the delivery of FYCOMPA 4 MG TABLET 30S, a medication. The contract has an ultimate completion date of April 2, 2025 and is a firm fixed-price contract. This award is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support...
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,568.41 Firm Fixed Price Delivery Order contract is for the supply of FYCOMPA 12 MG TABLET 30S, a pharmaceutical product. The contract has an ultimate completion date of November 20, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a leading global pharmaceutical sourcing and distribution services company. The contract is for the provision of the pharmaceutical product FYCOMPA 8 MG TABLET 30S, valued at $4,363.34, with a period of performance through March 19, 2024. The contract is a firm fixed price delivery order and does not have a set-aside designation. Additionally, AmerisourceBergen...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,421.01 delivery order contract is for the supply of FYCOMPA 4 MG TABLET 30S, a pharmaceutical product. The contract is a Firm Fixed Price (FFP) arrangement with a completion date of November 21, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that...
This is a delivery order award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The $4,455.20 firm fixed price contract is for the supply of FYCOMPA 0.5 MG/ML ORAL SUSP 340ML, a medication. The contract has a completion date of February 7, 2025 and is not designated as a set-aside. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
  • SPE2DB20D1100
    Indefinite Delivery Contract
  • SPE2DB20D1100-SPE2DB24FD8U9
    Delivery Order

This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of FYCOMPA 12 MG TABLET 30S. The contract has a period of performance through September 18, 2024 and a ceiling value of $5,158.92. This contract is not set-aside and is a firm fixed-price type. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued up to $999,999,999 through December 2025, which serves as a primary vehicle for providing a comprehensive range of medical commodities to support military treatment programs and facilities worldwide.

Generated 12/17/24, 9:27 AM